Level Four Advisory Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Level Four Advisory Services’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-457	Closed	-$30K	–	687
2021 Q1	$30K	Hold	457	–	–	﹤0.01%	627
2020 Q4	$16K	Hold	457	–	–	﹤0.01%	589
2020 Q3	$25K	Sell	457 -307	-40%	-$18.2K	﹤0.01%	537
2020 Q2	$29K	Hold	764	–	–	﹤0.01%	562
2020 Q1	$19K	Hold	764	–	–	﹤0.01%	485
2019 Q4	$37K	Hold	764	–	–	﹤0.01%	559
2019 Q3	$38K	Sell	764 -143	-16%	-$10.3K	﹤0.01%	501
2019 Q2	$83K	Sell	907 -3	-0.3%	-$365	0.01%	516
2019 Q1	$134K	Sell	910 -36	-4%	-$6.96K	0.01%	496
2018 Q4	$149K	Hold	946	–	–	0.02%	501
2018 Q3	$232K	Buy	946 +39	+4%	+$9.23K	0.03%	523
2018 Q2	$203K	Buy	+907	New	+$243K	0.01%	581

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

Level Four Advisory Services's DMK Position: Q2 2021 in Review

Level Four Advisory Services sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2021, closing a stake of 457 shares — an estimated $30K sold.

Level Four Advisory Services first reported a position in DMK in Q2 2018 and held it in 12 quarters. The position peaked at $232K in Q3 2018. 51 funds tracked by Wall St. Rank hold DMK as of Q2 2021.

Level Four Advisory Services reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2021 after selling out during the quarter.
Level Four Advisory Services sold 457 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2021, an estimated $30K.
Level Four Advisory Services first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2018 and held it in 12 quarters.
Level Four Advisory Services's DMK Pharmaceuticals Corporation Common Stock position peaked at $232K in Q3 2018.
51 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2021.

Based on Level Four Advisory Services's 13F filing for Q2 2021, filed 9 Aug 2021.